Part,  Chapter, Paragraph

  1    -,     1.  0.  0(1)|              be listed in Tables and Figures according to the official
  2    I,     2.  4       |              rate is calculated from figures at constant prices since
  3    I,     2.  5       |         recent European Commission’s figures, there are three million
  4    I,     2.  5       |              has increased. European figures from Eurostat show that
  5    I,     3.  3       |           expected in 2025. The EU27 figures are slightly less. This
  6    I,     3.  3       |             indicates that the NMS12 figures are significantly lower.
  7   II,     4.  1       |      increase was from 77 to 81. The figures are somewhat higher in the
  8   II,     4.  1       |           and 78 respectively. These figures indicate that the sex difference
  9   II,     4.  1       |          displayed, respectively, in Figures 4.1.1. and 4.1.2.~ ~Figure
 10   II,     5.  3.  2   |             European cancer survival figures are provided by the EUROCARE
 11   II,     5.  3.  3   |           according to the following figures (or set of them):~ ~ Cancer
 12   II,     5.  3.  3   |       survival by the end of 2008.~ ~Figures on cancer incidence, mortality
 13   II,     5.  3.  5   |             Maximum incidence rates (Figures 5.3.1) were estimated in
 14   II,     5.  3.  5   |             Maximum mortality rates (Figures 5.3.3) were estimated in
 15   II,     5.  3.  5   |             100,000, Figure 5.3.4b).~Figures 5.3.2 show that incidence
 16   II,     5.  3.  5   |        macro-areas. On the contrary, Figures 5.3.4 show that mortality
 17   II,     5.  3.  5   |           levels of incidence rates (Figures 5.3.5) were estimated in
 18   II,     5.  3.  5   |           levels of mortality rates (Figures 5.3.7) were estimated in
 19   II,     5.  3.  5   |              both for men and women (Figures 5.3.5 and Figures 5.3.7).
 20   II,     5.  3.  5   |             women (Figures 5.3.5 and Figures 5.3.7). Stomach cancer incidence (
 21   II,     5.  3.  5   |            Stomach cancer incidence (Figures 6) and mortality trends (
 22   II,     5.  3.  5   |             6) and mortality trends (Figures 5.3.8) are decreasing both
 23   II,     5.  3.  5   |         Europe (Ferlay et al, 2007). Figures 5.3.9 show that maximum
 24   II,     5.  3.  5   |              both for men and women (Figures 5.3.10) (65 new cases in
 25   II,     5.  3.  5   |         cases per 100,000 in women). Figures 5.3.11 show that Hungary,
 26   II,     5.  3.  5   |           incidence rates are lower.~Figures 5.3.13a and 5.3.15a show
 27   II,     5.  3.  5   |   macro-areas considered as shown in Figures 5.3.14a and 5.3.16a. In
 28   II,     5.  3.  6   |         cancer site. For this reason Figures 5.3.29 show 5-year relative
 29   II,     5.  3.  6   |           lowest level of prognosis (Figures 5.3.30). 5-year relative
 30   II,     5.  3.  6   |            cancer relative survival (Figures 5.3.31) was over than 48%
 31   II,     5.  3.  6   |      survival ~10% in men and women (Figures 5.3.32). Estimates of 1-
 32   II,     5.  4.  3   |             children that have lower figures, there does not seem to
 33   II,     5.  4.  3   |          EUCID 11 countries provided figures, ranging between 42% (Finland)
 34   II,     5.  4.  3   |        countries provided data, with figures between 0.1% (Netherlands,
 35   II,     5.  4.  4   |            50% in the countries with figures available for EUCID. However,
 36   II,     5.  4.  4   |             increasing. However, the figures currently available are
 37   II,     5.  5.  2   |           Kingdom. Consequently, the figures are an underestimation of
 38   II,     5.  5.  2   |          studies are as follows. The figures represent an estimate of
 39   II,     5.  5.  2   |           this may already seem, the figures presented in this report
 40   II,     5.  5.  3   |             and in certain incidence figures (gender, migrants, urbanicity).
 41   II,     5.  5.  3   |          2007). According to NOMESCO figures, the DDD sales of antipsychotics
 42   II,     5.  5.  3   |        Health in the EUKey facts, figures and activities http df~There
 43   II,     5.  5.  3   |         recorded, as epidemiological figures are unreliable and inconsistent.~ ~
 44   II,     5.  5.  3   |              are compared. Reference figures from the entire national
 45   II,     5.  6.  3   |             may be obtained from the figures of the progression of radiological
 46   II,     5.  6.  3   |             as OA is not reversible (Figures 5.6.3 and 5.6.4 and Tables
 47   II,     5.  6.  3   |       reflected in recent prevalence figures for RA from the UK which
 48   II,     5.  6.  3   |               0.86% and 0.51%. These figures are not directly comparable
 49   II,     5.  6.  3   |        unpredictable and prospective figures should be collected through
 50   II,     5.  6.  3   |   Osteoporosis Study, 2002). Similar figures have been found also in
 51   II,     5.  6.  3   |         whilst in men the comparable figures are 2.4% and 20%, respectively (
 52   II,     5.  7.  3   |          Figure 5.7.3), while higher figures are reported in medical
 53   II,     5.  7.  5   |             of their diseases. Early figures indicate that in the year
 54   II,     5.  8.  2   |             Health in Europe Facts & Figures, from European Lung White
 55   II,     5.  8.  5   |       publication includes the total figures of mortality, morbidity
 56   II,     5.  9.  2   |             Health in Europe Facts & Figures, from European Lung white
 57   II,     5.  9.  3   |             Health in Europe Facts & Figures, 2003 ERJ). The burden of
 58   II,     5.  9.  5   |      measures, it would be useful if figures and costs related to the
 59   II,     5.  9.  7   |            in Europe (2003): Facts & Figures, ERJ~ ~Mantovani L G, Bettoncelli
 60   II,     5. 12.  3   |              s have been reported in Figures 5.12.1 (A and B) and 5.12.
 61   II,     5. 15.  2   |            of RD in general. All the figures that are widely used have
 62   II,     5. 15.  3   |             in family members. These figures have been extracted from
 63   II,     5. 15.  3   |            lower than the prevalence figures typically presented in Europe.
 64   II,     6.  3.  1   |           report, national incidence figures thus often reflect activity
 65   II,     6.  3.  1(3)|         bring more clarity to actual figures for incidence, morbidity,
 66   II,     6.  3.  2   |              as well as low baseline figures (figure 6.1). However, two
 67   II,     6.  3.  3   |            tere is a general lack of figures for prevalence or incidence.
 68   II,     6.  3.  4   |             6.1. Selected tables and figures from the Tuberculosis Annual
 69   II,     6.  3.  5   |      diseases for which surveillance figures are most reliable: it is
 70   II,     7.  1       |          mentioned policy documents. Figures are coming from different
 71   II,     7.  2.  9   |            EuroCost projects provide figures for the medical costs of
 72   II,     7.  2.  9   |              summarisation of injury figures is rather difficult.~ ~ ~ ~
 73   II,     7.  3       |         report (EuroSafe, 2008).~The figures stated in this chapter represent
 74   II,     7.  3.  1   | Comprehensive View of Injuries~ ~The figures given in Table 7.1 are based
 75   II,     7.  3.  2   |               Based on the 2003-2005 figures for all ages, Lithuania
 76   II,     7.  3.  4   |              users in these absolute figures is likely to underestimate
 77   II,     7.  3.  4   |        comparability of the national figures are described in Chapter
 78   II,     7.  3.  5   |            above-mentioned mortality figures almost certainly underestimate
 79   II,     7.  4.  1   |             age~ ~According to these figures, actions should tackle severe
 80   II,     8.  1.  3   |              the poverty line. These figures compare with just under
 81   II,     9           |           2005; Garite et al, 2004). Figures 9.T1.1 and 9.T1.2. present
 82   II,     9.  1.  1   |           using EUROSTAT data, while Figures 9.1.1.1 and 9.1.1.2 show
 83   II,     9.  1.  2   |              are not included in the figures). Many rare genetic disorders
 84   II,     9.  1.  2   |         updates each year prevalence figures on 95 subgroups of congenital
 85   II,     9.  1.  2   |           2005; Garite et al, 2004). Figures 9.T1.1 and 9.T1.2. present
 86   II,     9.  2.  3   |      lymphoma as well as leukaemias (Figures 9.2.1a and b). Leukaemia
 87   II,     9.  2.  3   |           335.000 are injured. These figures represent about 10% of all
 88   II,     9.  3.  1   |            lifespan, while in Greece figures for both sexes are low in
 89   II,     9.  3.  1   |         Cancer in EuropeFacts and Figures. January http f (Article
 90   II,     9.  3.  1   |           Eurostat (2007): Europe in figures: Eurostat yearbook 2006-
 91   II,     9.  4.  3   |        cardiac pathologies.~ ~Global figures show that the WHO European
 92  III,    10.  2.  1   |          sexes show similar rates.~ ~Figures 10.2.1.1.2. 10.2.1.1.3.
 93  III,    10.  2.  1   |             and ecstasy, the average figures are 5.1% and 5% for lifetime
 94  III,    10.  2.  1   |            during this period. These figures are considered a minimum
 95  III,    10.  2.  1   |              2000a): EU Transport in figures. Statistical pocketbook.
 96  III,    10.  2.  1   |               This latter value also figures in the EURODIET guidelines
 97  III,    10.  3.  2   |              CEFIC (2005). Facts and Figures (as of January 2005). http://
 98  III,    10.  3.  3   |              medium and low baseline figures, shows that a general increase
 99  III,    10.  4.  2   |   Development(OECD), (2006): OECD in Figures 2006- 2007 edition~ ~The
100  III,    10.  4.  5   |            hazardous. Therefore, the figures on hazardous waste are not
101  III,    10.  5.  2   |              and recreational areas (Figures 10.5.2.2-10.5.2.4).~ ~Figure
102  III,    10.  5.  3   |          electricity supply. Maximum figures are observed in public administration
103  III,    10.  5.  3   |             general, slightly higher figures are reported by women in
104  III,    10.  5.  3   |      highlighted by first, providing figures on occupational diseases
105  III,    10.  5.  3   |        However, in 2003 and 2004 the figures seem to be quite stable.
106  III,    10.  5.  3   |         Romania saw increasing index figures.~Work accidents occur very
107  III,    10.  5.  3   |              has increased. European figures from Eurostat show that
108   IV,    11.  1.  2   |          majority of the comparative figures on health expenditure, health
109   IV,    11.  1.  2   |        countries and the comparative figures should be interpreted with
110   IV,    11.  5.  1   |          Figure 11.10. International Figures On Organ Donation and Transplantation~ ~
111   IV,    11.  5.  3   |             exportation are shown in Figures from 11.11 to 11.14.~ ~Figure
112   IV,    12. 10       |     drug-related deaths~based. These figures do not include deaths~which